Abeona Therapeutics to Report New Preclinical Data Demonstrating Therapeutic Potential of ABO-401 fo
NEW YORK and CLEVELAND, April 30, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and...
We Must Pay Closer Attention to the Global CF Population
Based on the stringent qualifications the Cystic Fibrosis Foundation uses to determine who has cystic fibrosis, approximately 70,000...
How Organ Transplant Works
The misconception that all patients in need of organ donation are responsible for their ill health should not suffice. Of course, there...
Common virus could speed up cystic fibrosis
A new study has found that cytomegalovirus, which is normally dormant in people who have it, can become active again in people with...
Cytomegalovirus – an unrecognised potential contributor to cystic fibrosis disease progression?
Given increasing body of work supporting an association of cytomegalovirus (CMV) seropositivity with several chronic medical conditions,...
Large Sugar Molecule Disrupts B. cepacia Bacteria from CF Patients, Study Shows
An experimental large sugar molecule called poly (acetyl, arginyl) glucosamine, or PAAG, was able to disrupt treatment-resistant biofilms...